IBANTI

This brand name is authorized in Ecuador

Active ingredients

The drug IBANTI contains one active pharmaceutical ingredient (API):

1 Lurasidone
UNII O0P4I5851I - LURASIDONE HYDROCHLORIDE

Lurasidone is a selective blocking agent of dopamine and monoamine effects indicated for the treatment of schizophrenia. Lurasidone binds strongly to dopaminergic D2- and to serotonergic 5-HT2A and 5-HT7 receptors. Lurasidone does not bind to histaminergic or muscarinic receptors.

Read about Lurasidone

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N05AE05 N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AE Indole derivatives
Discover more medicines within N05AE05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 5995-MEE-0321, 6186-MEE-0421

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈